Showing results (1221-1230 of 1,241) with videos related to
Sort By:
Pageof 125
Scientific Reports|January 9, 2023
Continuous exposure to isoprenaline reduced myotube size by delaying myoblast differentiation and fusion through the NFAT-MEF2C signaling pathwayJing Yue, Wei Xu, Li Xiang, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 27, 2020
Hsp70 Gene Polymorphisms Are Associated With Disease Susceptibility and HRQOL Improvement in Chinese Han Population With Systemic Lupus ErythematosusQiao-Mei Xie, Qiu-Yue Lou, Shun-Wei Huang, et al.The Lancet. Oncology|December 14, 2011
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.Current Biology : CB|April 14, 2026
Trophic cascades drive sustainability in the agricultural heritage rice-fish coculture systemNian-Feng Wan, Siyuan Shen, Muyao Li, et al.European Journal of Cancer (Oxford, England : 1990)|February 26, 2017
Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trialLei Chen, Chao-Su Hu, Xiao-Zhong Chen, et al.Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|September 26, 2017
[Expert consensus on the design and implementation of clinical safety centralized monitoring study of Chinese medical injection]Jun-Hua Zhang, Jing-Tian Ren, Jing-Qing Hu, et al.Therapeutics and Clinical Risk Management|January 14, 2021
Clinical Features for Severely and Critically Ill Patients with COVID-19 in Shandong: A Retrospective Cohort StudyShengyu Zhou, Jiawei Xu, Wenqing Sun, et al.Infectious Diseases of Poverty|August 27, 2020
A five-compartment model of age-specific transmissibility of SARS-CoV-2Ze-Yu Zhao, Yuan-Zhao Zhu, Jing-Wen Xu, et al.Vaccine|May 25, 2024
A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicityJin-Yuan Wu, Wei Zhang, Jing Pu, et al.Environment International|March 13, 2016
China's soil and groundwater management challenges: Lessons from the UK's experience and opportunities for ChinaFrédéric Coulon, Kevin Jones, Hong Li, et al.Pageof 125